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Over the past several years, the biochemical basis for PNH has come to be understood. The disease results from the emergence of a clone of hematopoietic stem cells in which there is defective synthesis of the glycosyl-phosphatidylinositol (GPI) anchor that is normally present on a variety of membrane proteins, including the complement regulatory proteins decay-accelerating factor (DAF, CD55) and the membrane inhibitor of reactive lysis (MIRL, CD59).7-9 Because they lack a GP1 anchor, these complement regulatory proteins are not expressed on the cell surface, and their absence on affected PNH erythrocytes makes the cells abnor- on the complement sensitivity of RBCs were described, it was suggested that AET exposure results in the disruption of membrane disulfide bonds." It has also been shown that antibodies to CD59MRL fail to bind to Western blots of RBC membranes when the sodium dodecyl sulfate-polyacrylamide gel electrophoresis is performed under reducing conditions"." and that AET-treated cells also fail to bind anti-MIRL.I3 Together, these findings suggest that disruption of intrachain disulfide bonds in MIRL by AET leads to functional inactivation of the molecule and results in the PNHlike defect present in AET-treated RBCs. In 1989, Biitikofer et a l l 4 published their findings that the GPI-anchored proteins, DAF and acetylcholinesterase are enriched compared with integral membrane proteins in the spectrin-free membrane vesicles released from RBCs calcium loaded by incubation with calcium and the ionophore A23187. On the basis of these findings, we hypothesized that calcium-loaded RBCs might have a PNH-like defect as a result of the loss of GPI-anchored complement regulatory proteins into vesicles. Calcium-loaded RBCs subsequently were found to have an increased susceptibility to hemolysis mediated by antibody and complement that was similar in degree to that of PNH I1 RBCs." In addition, there was a marked increase in susceptibility of calcium-loaded RBCs to reactive lysis (hemolysis mediated by the MAC).I5 Although there was a 50% decrease in the membrane content of CD55/ DAF and a 30% decrease in CD59/MIRL,'5 previous studies 2800 TEST AND MITSUYOSHI would suggest that decreases of this magnitude would alone be insufficient to account for the increased sensitivity of the cells to complement-mediated hemoly~is.'~ Finally, we found that correction of the losses of intracellular potassium and adenosine triphosphate (ATP) that result from calcium loading resulted in about a 60% decrease in the maximum amount of lysis observed in the reactive lysis assay." We concluded from these results that the abnormal susceptibility of calcium-loaded RBCs to complement-mediated lysis results from a complex combination of factors including decreases in immunoreactive and functional DAF and MIRL, potassium and ATP depletion, and possibly other undetermined cellular alteration^.'^ Thus, AET-treated and calcium-loaded RBCs both behaved like PNH I1 erythrocytes in assays of hemolysis mediated by antibody and complement and like PNH I11 cells in assays of reactive lysis. Because our studies on calciumloaded RBCs also suggested a defect in CD59/MIRL, as occurs in AET-treated cells, we initiated a side-by-side comparison of the two types of treatment on RBCs. As detailed below, we found that the two treatments have similar, but distinct effects on the ability of RBCs to regulate complement activation.
MATERIALS AND METHODS

Reagents and buffers.
Purified cobra venom factor (Naja naja kaouthia, CoF), C5, C6, C7, CS, C9, factor B, and factor D were obtained from Quidel, Inc (San Diego, CA). Activated CoF complexes (CoFBb) were prepared as previously described." C5b6 was prepared from purified C5 and C6 according to the method of Halperin et al. ' 6 Briefly, purified CoF, factor B, and factor D were incubated for 1 hour at 30°C in the presence of 2 mmoVL NiClz to generate the nickel-stabilized CoFBb convertase. Purified C5 and C6 were then added and the incubation continued for 3 hours at 37°C. The C5b6 complexes were either used immediately or frozen at -70°C in the presence of 25% glycerol. AET, bovine serum albumin (BSA), and calcium ionophore A23187 were from Sigma Chemical CO (St Louis, MO). Other reagents included gelatin (Difco, Inc, Detroit, MI) and protein A-Sepharose CL-4B (Pharmacia-LKB, Uppsala, Sweden).
The following buffers were used: Tris-buffered saline ( Erythrocytes. Erythrocytes were obtained from the peripheral venous blood of healthy adult donors. The blood was anticoagulated with heparin and subsequently washed three times with 0.9% saline.
Calcium loading and AET treafmenl of norma/ erythrocytes. Erythrocytes at a hematocrit of -18% were equilibrated in TBS supplemented with 0.2% glucose and 1 mmol/L CaZ' for 5 minutes at 37°C. Subsequently, the calcium ionophore A23187 was added to the RBC suspension from a 10-mmoVL stock solution in ethanol to give a final concentration of 4 pmol/L. The incubation was continued for 1 hour at 37°C and terminated by the addition of an equal volume of TBS containing 5 mmol/L EDTA to the suspension and incubation for an additional 5 minutes at room temperature. The RBCs were then pelleted, resuspended in TBS containing 2 mmol/ L EDTA and 2% BSA, and incubated for 15 minutes at 37°C. They were washed twice in the same buffer, followed by three washes in TBS containing 2 mmoUL EDTA.
Erythrocytes were treated with AET by incubation at a hematocrit of 20% with AET at a final concentration of 64 mg/mL for exactly 9 minutes at 37°C followed by extensive washing with 0.9% NaCI.
The AET was added from a freshly prepared stock solution at 80 mg/mL in HzO, pH 8.0. Hemolysis mediated by antibody and complement. Hemolysis of RBCs by antibody and complement was determined using a slight modification of the complement lysis sensitivity assay of Rosse and Dacie" as previously de~cribed.'~ Briefly, RBCs (2 x lO*/mL) were mixed 1:l with a 1/30 dilution of commercial rabbit anti-human RBC (1gG fraction) and incubated for 1 hour at 37°C with incremental dilutions of normal human serum (NHS) in DGVB2' in a final volume of 0.375 mL. The incubation was terminated by the addition of 1 mL of 0.9% saline containing 15 mmollL NazEDTA (NS-EDTA), and the red cells were removed by centrifugation. Duplicate 100-pL samples of supernatant were placed in microtiter wells and read using a Dynatech MR700 microplate reader (Dynatech Laboratories Inc, Chantilly, VA) at a test wavelength of 410 nm and a reference wavelength of 630 nm. Hemolysis was determined by comparing the absorbance of supernatants with that from a 100% lysis control consisting of antibody-coated RBCs incubated with water instead of buffer. Spontaneous hemolysis was determined by incubating antibody-treated cells with buffer in the absence of serum.
Hemolysis mediated by the membrane attack complex of complement (reactive lysis). Reactive lysis was initiated by the addition of either CoFBb or isolated C5b6. Hemolysis initiated by C o m b was performed as described previously.'' When reactive lysis was initiated by C5b6, RBCs (50 pL at 5 X 108/mL in DGVB) were incubated with 25 pL of C5b6 (U10 dilution of the stock preparation) for 20 minutes at room temperature, C7 (1 pg in 25 pL) was added and the incubation continued for an additional 20 minutes, followed by the addition of incremental concentrations of a mixture of C8 and C9 containing from 39.1 to 625 ng of each component in 100 pL and incubation for 40 minutes at 37°C. A total of 1 mL of NS-EDTA was added and the cells pelleted by centrifugation. Hemolysis was determined by comparing the absorbance of supernatants with that from a 100% lysis control consisting of 50 pL of erythrocytes incubated with 150 pL of water. Spontaneous hemolysis was determined by incubating RBCs alone with either buffer or with buffer and the highest concentration of C8 and C9 in the absence of C5b6 and C7. Normal, calcium-loaded, or AET-treated RBCs (50 pL at 5 X lo8/ mL in DGVB+-EGTA, pH 6.4) were incubated with 100 pL of the appropriate dilution of NHS-MgC1,-EGTA at 37°C for 30 minutes. After the incubation, 1 mL of NS-EDTA was added to each of the tubes, and the erythrocytes were removed by centrifugation. Hemolysis was determined by comparing the absorbance of the supernatant with a 100% lysis control in which 50 pL of the cell suspension was incubated with 100 pL of water. As a control, NHS-EDTA was substituted for NHS-MgC1,-EGTA.
Binding of C5b-7 and C9 to erythrocytes. Binding of C5b-7 to erythrocytes was measured using IzI-C7 and binding of C9 was measured using '*'I-C9 as previously described."
Binding ofC3b to erythrocytes. Binding of C3b and its degradation fragments to erythrocytes incubated in acidified serum was measured using a radioiodinated monoclonal antibody to C3d. RBCs (50 pL of a 5 X 108/mL suspension) were incubated with 100 pL of either undiluted NHS-MgC1,-EGTA, pH 6.4 or NHS-EDTA, pH 6.4 for 30 minutes at 37"C, followed by the addition of 1 mL of NS-EDTA. The cell suspension was then transferred to a 1.5-mL microcentrifuge tube and centrifuged at 15,800g for 15 minutes at 4°C to pellet both intact and hemolyzed RBCs. 'Ihe cell pellet was resuspended in 100 pL of DGVB-EDTA, pH 7.4. Duplicate 40-pL aliquots of the suspension were placed in 12 X 75 mm polypropylene tubes and incubated with 50 pL of '=I-anti-C3d (20 pg/mL in DGVB-EDTA) for 30 minutes at 37°C. Seventyfive microliters of the suspension was then carefully layered over 200 pL of cold 20% sucrose in a 400 pL polyethylene microcentrifuge tube and centrifuged (15 minutes, 15,700g, 4°C) to separate free from bound '=I-anti-C3d. The tip of the microcentrifuge tube containing the cell pellet was severed, and radioactivity was determined in a gamma counter. Nonspecific binding of "%anti-C3d was determined from the tubes in which NHS-EDTA was substituted for NHS-MgC1,-EGTA in the acidified serum incubation. The quantity of anti-C3d bound was calculated based on a molecular weight of 150 kD for the antibody.
Effect of treatment with anti-MIRL on RBC susceptibility to acid$ed serum lysis. Normal and calcium loaded RBCs were suspended to 5 X l@/mL in DGVB-EDTA, pH 7.5. Fifty microliters of the cell suspension was incubated with incremental amounts of purified rabbit anti-MIRL IgG (0 to 50 pg) for 30 minutes at 37°C. The cells were washed with DGVB+-EGTA, pH 6.4 and resuspended to 5 X 108/mL in DGVB+-EGTA, pH 6.4. The RBCs were incubated with 100 pL of undiluted NHS-MgC12-EGTA, pH 6.4 (or undiluted NHS-EDTA, pH 6.4 as a control) for 30 minutes at 37°C. After incubation, 1 mL of NS-EDTA was added to each tube, the cells were pelleted, and hemolysis determined. Binding of C3b and C9 to the RBCs incubated with 25 pg and 50 pg of a n t i -= IgG was also determined. 
RESULTS
Complement lysis sensitivity of calcium-loaded versus AET-treated erythrocytes.
The susceptibility of calcium- 1 SD, n = 3). Although AET-treated RBCs were more sensitive to hemolysis in the complement lysis sensitivity assay than were calcium loaded erythrocytes, the range of enhancement in hemolysis by the two treatments (2.5 to 6.8 times the value for control RBCs) was similar in degree to that previously reported for PNH I1 e~ythrocytes.~-'
Reactive lysis of calcium-loaded versus AET-treated erythrocytes. Two different assay systems were used to determine the susceptibility of RBCs to reactive lysis. First, RBCs were incubated with C o m b in EDTA-chelated human serum to generate C5b6, the serum also serving as a source of C7, C8, and C9. In this assay, the maximum hemolysis observed for calcium-loaded and AET-treated RBCs was similar, with maximums of 67.4% ? 4.2% (n = 4) for calcium-loaded cells and 82.1% t 5.2% for AET-treated cells (Fig 1) . In addition, reactive lysis was measured in an incubation mixture consisting of RBCs and purified C5b6 complexes, followed by purified C7, and then a mixture of purified C8 and C9 (Fig 2) . Under these conditions, the curves for calcium-loaded and AET-treated erythrocytes were nearly identical, with maximum lysis approaching 100%.
Binding of C5b-7 and C9 to calcium-loaded and AETtreated erythrocytes.
To determine the mechanisms responsible for the increased susceptibility of calcium-loaded and AET-treated RBCs to reactive lysis, we examined C5b-7 and C9 binding to RBCs in the assay system using purified The cells were washed and incubated with C5b6 ( l / l O dilution of a stock preparation), followed by C7 (l pgI, followed by increasing amounts of a mixture of C8 and C9, containing from 39.1 t o 625.0 ng of each component. Cells then were removed by centrifugation and supernatants were analyzed for hemolysis. Each point represents the mean 2 SD of four experiments. components (Fig 3) . Two different dilutions of C5b6 were used. When '/,-diluted C5b6 complexes were used, calciumloaded RBCs bound 3,015 t 271 moleculesiRBC of C5b-7 and 2,705 t 1,001 molecules/RBC of C9 compared with 2,123 t 246 molecules/RBC of C5b-7 and 2,259 -C 1 19 moleculesiRBC of C9 for control RBCs. In both cases, the C9/C7 ratio approximated one (1.08 t 0.14 for control RBCs and 0.89 t 0.32 for calcium-loaded RBCs). In contrast, AET-treated cells bound 2.1 1 t 0.14 times as much C9 (3,411 t 493 moleculesiRBC) as C7 ( I ,622 t 219 moleculesRBC), consistent with defective function of CD59/ MIRL. When the C5b6 complexes were further diluted by a factor of 4, the differences between the calcium-loaded and AET-treated erythrocytes became even more apparent (Fig 3B) . Under these conditions, the C9/C7 ratios were 2.06 2 0.59 for control RBCs, 1.54 t 0.90 for calcium-loaded RBCs, and 7.15 t 2.67 for AET-treated RBCs.
Acidified serum lysis of calcium-loaded versus AETtreated erythrocytes. Because AET-treated RBCs are known to be susceptible to hemolysis in acidified serum, we compared cells treated by the two different methods in this assay as well. As can be seen in Fig 4, neither control nor calcium-loaded erythrocytes hemolyzed in acidified serum, whereas AET-treated cells showed a linear correlation between the input of acidified serum and the amount of hemolysis, reaching a maximum of 63.7% 2 12.3% lysis at the highest input of acidified serum. These results suggest that regulation of the alternative pathway of complement is normal on calcium-loaded erythrocytes.
Binding of C3b to calcium-loaded versus AET-treated erythrocytes incubated in acidified serum. Binding of C3b and its fragments to RBCs incubated in acidified serum also was examined using a radioiodinated monoclonal antibody to C3d (Fig 5) . As expected from the results in the acidified serum lysis assay, control and calcium-loaded erythrocytes bound relatively low amounts of "'I-anti-C3d the susceptihilim qf calcium-loaded entltmcytes to acidified serum lysis. In addition to its ability to inhibit assembly of the MAC, CDS9NIRL previously has been shown to be critically important in regulating activation of the alternative pathway of complement when normal human RBCs are incubated in acidified serum.2".22 Thus, we blocked the function of CDS9NIRL in calcium-loaded RBCs with anti-MIRL IgG before incubation in acidified serum to determine whether calcium-loaded RBCs would exhibit increased levels of hemolysis compared with normal erythrocytes when complement was activated on the cells before formation of the MAC. Preincubation of the RBCs with anti-MIRL would by itself facilitate assembly of the MAC on the cell membrane independent of any effects of calcium loading, but hemolysis would be observed only if the cell's defenses against alternative pathway activation were also inhibited by the anti-MIRL. The effect of preincubating cells with antiMlRL IgG on lysis in acidified serum is shown in Fig 6A. The amount of anti-MIRL added that resulted in hemolysis of SO% of the calcium-loaded cells was about one third of that which resulted in hemolysis of half of the control RBCs. Examination of the amounts of C3b and C9 bound to the RBCs after incubation in acidified serum (Fig 6B) showed that following preincubation with 25 pg of anti-MIRL IgG, calcium-loaded RBCs were more susceptible than normal cells to hemolysis in acidified serum despite the fact that they bound equivalent amounts of C3b and C9. After preincubation with 50 pg of anti-MIRL IgG, calcium-loaded erythrocytes were hemolyzed to a similar degree as the control cells, but had lower levels of bound C3b and C9. These results, coupled with those shown in Figs 2 and 3 , suggest that calcium-loaded cells are hemolyzed more efficiently by the MAC than are normal RBCs whether the CSb-9 complex is formed as a consequence of alternative pathway activation or is generated in reactive lysis systems.
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DISCUSSION
The studies reported here show that AET-treated and calcium-loaded erythrocytes have several features in common with respect to altered regulation of activated complement. Compared with untreated RBCs. calcium-loaded and AETtreated cells have an increased susceptibility to lysis by antibody and complement that is similar to that observed for PNH I1 RBCs.".'' They also have a comparable increase compared with control RBCs in their sensitivity to hemolysis mediated by the CSb-9 membrane attack complex in assays using either CoFBb and serum or CSb6, C7, C8, and C9. However, the results obtained in assays of CSb-7 and C9 binding and of lysis in acidified serum suggest that there are important differences between the effects of the two treatments and that the mechanisms underlying the altered complement regulation differ for AET-treated and calciumloaded RBCs. Although data from previous studies suggest that AET treatment of RBCs results in structural alterations in CDS9/MIRL.""" the mechanisms responsible for altered complement regulation in calcium-loaded RBCs are unknown.
Calcium-loaded and AET-treated RBCs were hemolyzed to similar degrees in assays of reactive lysis but, as noted above. differences in the binding of CSb-7 and C9 to these cells suggest that different mechanisms were responsible for the observed effects. AET-treated cells showed a slight de- RBCs is consistent with functional inactivation of CD59/ MIRL. In contrast, calcium-loaded erythrocytes bound slightly increased amounts of C5b-7 compared with control RBCs, but bound similar amounts of C9, resulting in a slight decrease in the C9/C7 ratio compared with control cells. Thus, it is likely that the increased susceptibility to reactive lysis of calcium-loaded cells results from cellular alterations distinct from the loss of CD59/MIRL activity. This is also apparent from experiments in which calcium loading of RBCs in high K' buffers significantly decreased the maximum amount of hemolysis subsequently seen when reactive lysis was initiated by CoFBb." Incubation with Ca2' and A23 187 under these conditions prevents the usual decreases in intracellular K' and cell volume and some of the membrane vesiculation that ordinarily occurs as a consequence of calcium loading. Finally, normal resistance to reactive lysis was not reconstituted in calcium-loaded RBCs preincubated with purified CD59IMIRL (Test ST, Mitsuyoshi J, unpublished observation).
Susceptibility to hemolysis and binding of C3b in acidified serum was increased only for AET-treated RBCs and not calcium-loaded cells, an indication of additional differences in the complement regulatory activities of the two types of cells. As noted above, CD59MIRL is the membrane protein primarily responsible for protecting RBCs from acidified serum lysis, in addition to its role in guarding cells from MIRL. 23 .24 Thus, the increased C9 binding to AET-treated C5b-9-mediated hemo1ysis.20-22 Thus, CD59lMIRL function is intact on calcium-loaded cells with respect to both regulation of MAC formation and regulation of alternative pathway activation. When RBCs were preincubated with anti-MIRL IgG before incubation with acidified serum, thus allowing alternative pathway activation to proceed on the cell membrane, calcium-loaded cells were hemolyzed to a greater degree than control RBCs, but bound similar amounts of both C3b and C9. These data show that equivalent amounts of bound C3b and C9 lead to more efficient hemolysis of calcium-loaded compared with control RBCs.
Previous investigations into the mechanism of binding of the MAC to the cell membrane have suggested certain membrane characteristics that favor insertion of the MAC into the membrane." These characteristics include increased surface curvature and the presence of longer fatty acyl side chains and/or negatively charged headgroups on membrane phospholipids in the outer leaflet.2s All of these structural features would share the common end result of decreasing lipid packing and better exposing hydrocarbon binding sites on membrane phospholipids thus, at least hypothetically, permitting deeper insertion of C5b-7 (or the entire MAC) into the membrane bilayer." Exposure of RBCs to calcium and ionophore A23 187 induces at least two of these structural changes that could exert a favorable influence on binding of the MAC. First, decreases in cell volume that occur as a result of activation of the calcium-activated potassium (Gardos) channelI5 would increase cell curvature. Second, there is a loss in membrane phospholipid asymmetry that leads to surface exposure of phosphatidylserine,2"3n a negatively charged aminophospholipid that is normally confined to the inner leaflet of the membrane bilayer.".'2 Alterations in binding of the MAC to the cell membrane of calcium-
